CompletedNCT03195244AT&ASDUpdated Apr 21, 2022

Aquatic Therapy and Autism Spectrum Disorders

An interventional study of Aquatic Physical Therapy in Autism Spectrum Disorder, sponsored by Sloan W. Rush, MD. Completed at 1 site in United States. Open to participants aged 3 Years to 17 Years. Per ClinicalTrials.gov, last updated 2022-04-21.

Sponsored by Sloan W. Rush, MD · Not applicable, Interventional, and Treatment

Phase: Not applicable
Study type: Interventional
Enrollment: 50
Allocation: Randomized
Ages: 3 Years to 17 Years
Sex: All

Study summary

To compare the efficacy of one-on-one versus group-based aquatic therapy on the social interactions, behaviors and physical activities of children with autism spectrum disorders (ASDs).

Conditions studied

Autism Spectrum Disorder

Browse trials for

Keywords

aquatic therapy, hydrotherapy

Who can participate

Ages eligible: 3 Years to 17 Years
Sexes eligible: All
Accepts healthy volunteers: No

Eligibility criteria

Eligibility criteria:

DSM-V diagnosis of Autism Spectrum Disorder or DSM-IV diagnosis of Asperger's syndrome or high functioning atypical autism or pervasive development disorder - not otherwise specified or else the typical clinical findings and suspicion of an ASD
Treatment naïve to prior aquatic therapy

Exclusion criteria:

Not willing to undergo an investigational treatment
Unable to cooperate well enough to safely participate in aquatic therapy under the protocol guidelines
Known allergies to pool chemicals
Other significant co-morbidities which may include (but is not limited to): severe cerebral palsy with low motor function, advanced pulmonary disease, home oxygen requirement, spina bifida with low motor function, permanent feeding tubes, poorly controlled seizure disorder, chronic indwelling urinary catheters or any condition causing severe cognitive impairment

Study design

Phase: Not applicable
Primary purpose: Treatment
Allocation: Randomized
Intervention model: Parallel assignment
Masking: Double (Participant, Outcomes assessor)
Enrollment: 50 participants (actual)

Study arms

No intervention
Observation
Active comparator
One-on-one Aquatic Therapy
Other: Aquatic Physical Therapy
Experimental
Group Aquatic Therapy
Other: Aquatic Physical Therapy

Interventions

OtherAquatic Physical Therapy
Swim Whisperer's Aquatic Therapy Sessions

What researchers measure

Primary outcomes

Change in PedsQL Score
Survey
Time frame: Baseline and 10 weeks after intervention

Study locations

1 site

Turn Center
Amarillo, Texas 79106, United States

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

Registry details

Key details

Study ID: NCT03195244
Lead sponsor: Sloan W. Rush, MD
Responsible party: Sloan W. Rush, MD (MD, Panhandle Eye Group, LLP) — Sponsor-investigator
First posted: Jun 22, 2017
Start date: Jun 12, 2017
Primary completion: Apr 12, 2022
Completion: Apr 12, 2022
Last update: Apr 21, 2022

Oversight

Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Autistic Disorder→

Other studies from this sponsor

Sloan W. Rush, MD

Start the discussion